Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.

Lehmann JM, Claus K, Jansen C, Pohlmann A, Schierwagen R, Meyer C, Thomas D, Manekeller S, Claria J, Strassburg CP, Trautwein C, Wasmuth HE, Berres ML, Trebicka J.

Liver Int. 2018 May;38(5):875-884. doi: 10.1111/liv.13610. Epub 2017 Nov 6.

PMID:
29105936
2.

A lateral cephalometry study of patients with neurofibromatosis type 1.

Friedrich RE, Lehmann JM, Rother J, Christ G, Zu Eulenburg C, Scheuer HT, Scheuer HA.

J Craniomaxillofac Surg. 2017 Jun;45(6):809-820. doi: 10.1016/j.jcms.2017.02.011. Epub 2017 Feb 20.

PMID:
28365079
3.

Fibrinolytic treatment of acute arterial occlusion distal to the wrist in two cases.

Witz M, Sagiv P, Lehmann JM.

J Hand Surg Eur Vol. 2008 Jun;33(3):342-4. doi: 10.1177/1753193408090109.

PMID:
18562369
4.

[Stents in dialysis vascular access--do they promise improved high quality prolonged access use].

Klein O, Plotkin E, Gritun I, Verner M, Lehmann JM, Rathaus M, Bernheim J.

Harefuah. 2008 Feb;147(2):103-6, 184. Hebrew.

PMID:
18357663
5.

Carotid surgery in the octogenarians. Should patients' age be a consideration in carotid artery endarterectomy?

Witz M, Witz S, Shnaker A, Lehmann JM.

Age Ageing. 2003 Jul;32(4):462-3. No abstract available.

PMID:
12851198
6.

Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathways.

Shiau AK, Coward P, Schwarz M, Lehmann JM.

Curr Opin Drug Discov Devel. 2001 Sep;4(5):575-90. Review.

PMID:
12825453
7.

Secondary aortoduodenal fistula.

Witz M, Lehmann JM, Shnaker A, Pomeranz I, Leichtman G, Novis B.

Isr Med Assoc J. 2002 Oct;4(10):824. No abstract available.

8.

Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.

Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL.

Endocrinology. 2002 Jun;143(6):2376-84.

PMID:
12021203
9.

Delayed carotid artery rupture in advanced cervical cancer--a dilemma in emergency management.

Witz M, Korzets Z, Shnaker A, Lehmann JM, Ophir D.

Eur Arch Otorhinolaryngol. 2002 Jan;259(1):37-9.

PMID:
11954924
10.

Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital.

Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, Negishi M.

Mol Pharmacol. 2002 Jan;61(1):1-6.

PMID:
11752199
11.

Effects of fenofibrate on lipid parameters in obese rhesus monkeys.

Winegar DA, Brown PJ, Wilkison WO, Lewis MC, Ott RJ, Tong WQ, Brown HR, Lehmann JM, Kliewer SA, Plunket KD, Way JM, Bodkin NL, Hansen BC.

J Lipid Res. 2001 Oct;42(10):1543-51.

12.

4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma.

Coward P, Lee D, Hull MV, Lehmann JM.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8880-4. Epub 2001 Jul 10.

13.

Arterial thromboembolism from a distal aortic thrombus in a patient with Crohn's disease.

Lehmann JM, Shnaker A, Silverberg D, Dayan K, Witz M.

Isr Med Assoc J. 2001 Mar;3(3):226-7. No abstract available.

14.

Acute thrombosis of an aortic aneurysm.

Shnacker A, Witz M, Lehmann JM.

J Cardiovasc Surg (Torino). 2001 Feb;42(1):111-3.

PMID:
11292917
15.

Isolated femoral profundoplasty using endarterectomised superficial femoral artery for limb salvage in the elderly.

Witz M, Shnacker A, Lehmann JM.

Minerva Cardioangiol. 2000 Dec;48(12):451-4.

PMID:
11253330
16.

Prevention of side branch endoleaks with thrombogenic sponge: one-year follow-up.

Lehmann JM, Macierewicz JA, Davidson IR, Whitaker SC, Wenham PW, Hopkinson BR.

J Endovasc Ther. 2000 Oct;7(5):431-3. No abstract available.

PMID:
11032264
17.

Retroperitoneal haematoma - a serious vascular complication of cardiac catheterisation.

Witz M, Cohen Y, Lehmann JM.

Eur J Vasc Endovasc Surg. 1999 Oct;18(4):364-5. No abstract available.

18.

The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.

Kliewer SA, Lehmann JM, Milburn MV, Willson TM.

Recent Prog Horm Res. 1999;54:345-67; discussion 367-8. Review.

PMID:
10548883
19.

A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity.

Brown PJ, Winegar DA, Plunket KD, Moore LB, Lewis MC, Wilson JG, Sundseth SS, Koble CS, Wu Z, Chapman JM, Lehmann JM, Kliewer SA, Willson TM.

J Med Chem. 1999 Sep 23;42(19):3785-8. No abstract available.

PMID:
10508427
20.

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Brown KK, Henke BR, Blanchard SG, Cobb JE, Mook R, Kaldor I, Kliewer SA, Lehmann JM, Lenhard JM, Harrington WW, Novak PJ, Faison W, Binz JG, Hashim MA, Oliver WO, Brown HR, Parks DJ, Plunket KD, Tong WQ, Menius JA, Adkison K, Noble SA, Willson TM.

Diabetes. 1999 Jul;48(7):1415-24.

PMID:
10389847
22.

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102-6.

23.

Bile acids: natural ligands for an orphan nuclear receptor.

Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM.

Science. 1999 May 21;284(5418):1365-8.

24.

Orphan nuclear receptors: shifting endocrinology into reverse.

Kliewer SA, Lehmann JM, Willson TM.

Science. 1999 Apr 30;284(5415):757-60. Review.

PMID:
10221899
25.

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.

Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV.

Mol Cell. 1999 Mar;3(3):397-403.

26.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WW Jr, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RA Jr, Noble SA, Oliver W Jr, Parks DJ, Plunket KD, Szewczyk JR, Willson TM.

J Med Chem. 1998 Dec 3;41(25):5020-36.

PMID:
9836620
27.

Subclavian artery aneurysms. A report of 2 cases and a review of the literature.

Witz M, Yahel J, Lehmann JM.

J Cardiovasc Surg (Torino). 1998 Aug;39(4):429-32. Review.

PMID:
9788786
28.

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA.

J Clin Invest. 1998 Sep 1;102(5):1016-23.

29.

Cloning and characterization of human estrogen receptor beta isoforms.

Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM, Willson TM.

Biochem Biophys Res Commun. 1998 Jun 9;247(1):75-8.

PMID:
9636657
30.

An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.

Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterström RH, Perlmann T, Lehmann JM.

Cell. 1998 Jan 9;92(1):73-82.

31.

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library.

Brown PJ, Smith-Oliver TA, Charifson PS, Tomkinson NC, Fivush AM, Sternbach DD, Wade LE, Orband-Miller L, Parks DJ, Blanchard SG, Kliewer SA, Lehmann JM, Willson TM.

Chem Biol. 1997 Dec;4(12):909-18.

32.

Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways.

Lenhard JM, Kliewer SA, Paulik MA, Plunket KD, Lehmann JM, Weiel JE.

Biochem Pharmacol. 1997 Oct 1;54(7):801-8.

PMID:
9353134
33.

Activation of the orphan receptor RIP14 by retinoids.

Zavacki AM, Lehmann JM, Seol W, Willson TM, Kliewer SA, Moore DD.

Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7909-14.

34.

Major vascular injury during laparoscopy.

Witz M, Lehmann JM.

Br J Surg. 1997 Jun;84(6):800. No abstract available.

PMID:
9189091
35.

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4318-23.

36.

Aneurysmal arterial disease in a patient with Ehlers-Danlos syndrome. Case report and literature review.

Witz M, Lehmann JM.

J Cardiovasc Surg (Torino). 1997 Apr;38(2):161-3. Review.

PMID:
9201128
37.

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.

Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA.

J Biol Chem. 1997 Feb 7;272(6):3406-10.

38.

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway.

Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM.

J Biol Chem. 1997 Feb 7;272(6):3137-40.

39.

Fluorescent microtiter screening assay for immunocytochemically reactive antibodies.

Su JL, Kilpatrick KE, Champion BR, Morris DC, Lehmann JM, Kost TA.

Biotechniques. 1997 Feb;22(2):320-4.

40.

Discovery of ligands for the nuclear peroxisome proliferator-activated receptors.

Willson TM, Lehmann JM, Kliewer SA.

Ann N Y Acad Sci. 1996 Dec 27;804:276-83.

PMID:
8993550
41.

Ruptured aneurysm of the renal artery in a woman with a solitary kidney.

Witz M, Lehmann JM.

Eur J Surg. 1996 Dec;162(12):989-91. No abstract available.

PMID:
9001883
42.

Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation.

Tai TA, Jennermann C, Brown KK, Oliver BB, MacGinnitie MA, Wilkison WO, Brown HR, Lehmann JM, Kliewer SA, Morris DC, Graves RA.

J Biol Chem. 1996 Nov 22;271(47):29909-14.

43.

Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.

Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC.

Mol Pharmacol. 1996 Nov;50(5):1087-94.

PMID:
8913339
44.

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.

Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM.

J Med Chem. 1996 Feb 2;39(3):665-8. No abstract available.

PMID:
8576907
45.

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM.

Cell. 1995 Dec 1;83(5):813-9.

46.

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA.

J Biol Chem. 1995 Jun 2;270(22):12953-6.

47.

Transient femoral nerve palsy complicating preoperative ilioinguinal nerve blockade for inguinal herniorrhaphy.

Lehmann JM, Beckermann S.

Br J Surg. 1995 Jun;82(6):853. No abstract available.

PMID:
7503874
48.
49.

Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching.

Lehmann JM, Zhang XK, Graupner G, Lee MO, Hermann T, Hoffmann B, Pfahl M.

Mol Cell Biol. 1993 Dec;13(12):7698-707.

50.

Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.

Jong L, Lehmann JM, Hobbs PD, Harlev E, Huffman JC, Pfahl M, Dawson MI.

J Med Chem. 1993 Sep 3;36(18):2605-13.

PMID:
8410972

Supplemental Content

Loading ...
Support Center